Role of angiotensin-converting enzyme insertion/deletion and plasminogen activator inhibitor-1 4G/5G gene polymorphisms in retinal vein occlusion
Open Access
- 1 November 2005
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (11) , 2583-2584
- https://doi.org/10.1111/j.1538-7836.2005.01591.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levelsThrombosis and Haemostasis, 2004
- Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriagesHuman Reproduction, 2003
- The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial diseaseAtherosclerosis, 2002
- PAI‐1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organsAmerican Journal of Hematology, 2002
- Thrombophilic Risk Factors in Patients with Central Retinal Vein OcclusionThrombosis and Haemostasis, 2001
- Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patientsKidney International, 2000
- Heritable Thrombophilia and HypofibrinolysisArchives of Ophthalmology (1950), 1999
- The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous ThromboembolismThrombosis and Haemostasis, 1998
- PAI-1 Plasma Levels in a General Population Without Clinical Evidence of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- An Alternative Method for PAI-1 Promoter Polymorphism (4G/5G) TypingThrombosis and Haemostasis, 1997